Navigation Links
Novel Technology Breaks Through Cancer Pain
Date:8/19/2007

MORRISVILLE, N.C., Aug. 16 /PRNewswire/ -- Cancer patients fraught with flare-ups of pain, or breakthrough pain, may soon receive some assistance in the form of a new easy-to-use oral drug delivery system developed by BioDelivery Sciences designed to quickly deliver pain medication.

Cancer patients frequently experience two types of pain: persistent and breakthrough. Persistent cancer pain is characterized as continuous pain present for long periods of time, and often most of the day. Persistent pain is treated by daily or regular doses of pain medication.

Breakthrough pain is a brief and often severe shooting of pain that "breaks through" a patient's continuous medication for persistent pain. Breakthrough pain often has a rapid onset and lasts a short duration of time. It is called breakthrough pain because it "breaks through" a regular pain medicine schedule.

"Breakthrough pain is caused either by the cancer itself or the cancer treatment. For some patients, the pain is connected to certain activities, such as walking or dressing. For others, it occurs unexpectedly," says Dr. Andrew Finn, BioDelivery Sciences' VP of Product Development.

One breakthrough pain medication is the opiate fentanyl. Fentanyl is a potent opioid analgesic (painkiller) first developed in the 1950s, and long in use by the medical community for controlling various types of pain.

The next generation product able to quickly deliver fentanyl for the treatment of cancer breakthrough pain is a patient-friendly, small oral adhesive disc called BEMA Fentanyl, which has recently completed Phase III trials by BioDelivery Sciences. The BEMA technology is a very small layered disc that is applied to a mucosal surface (inner lining of the mouth) in a similar way a transdermal disc is applied to the skin.

The small disc is composed of an adhesive layer and a non-adhesive backing layer. The disc adheres to the inside cheeks and delivers the dose of medication quic
'/>"/>

SOURCE BioDelivery Sciences

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2

Related biology technology :

1. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
2. High-Fidelity PCR with a Novel Polymerase Mixture
3. Challenge the Performance of Your Hot-Start PCRs with FastStart Taq DNA Polymerase and the Novel FastStart High Fidelity PCR System
4. Combine High Yield, Great Accuracy and the Prevention of Carry-over Contamination by Using the Novel Expand High FidelityPLUS PCR System
5. Novel MicroRNA Array Technology for Sensitive miRNA Profiling
6. A Novel Process for Gene Expression Profiling of Rat and Mouse Tissues from Formalin-Fixed Paraffin-Embedded Sections Using Microarrays
7. Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors
8. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications
9. Novel Bonding Chemistry Imparts Enhanced Polar Selectivity to TSK-GEL ODS-100V Reversed Phase Columns
10. Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins
11. Life-sciences conference to feature novel research with clinical potential

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)... This webinar, which will ...anyone working in continuous flow chemistry proces...R flow cell inline using various meso and micro sc...k of over 670 publications has been recognized wit... most recently the 2009 Tetrahedron Prize. , ...
(Date:11/4/2009)..., HUNTSVILLE, Ala., Nov. 4 DIAT...RIX.com ), today presented at the Michigan Securi...ference in Dearborn, Mich. Dennis Grimaud, Chairma...ned the impact of the company,s advanced molecular...response, infectious disease diagnosis and militar...
(Date:11/4/2009)..., ,, ROCKVILLE, Md., Nov. 4 /PRNewswire/...cs company focused on next-generation antibody dru... $10 million in Series A funding from New Enterpri...nture capital firms. The capital will be used to c...s that address two or more biological targets with...
(Date:11/4/2009)..., SAN CARLOS, Calif., Nov. 4 /PRNewswire-FirstC... reported its financial results for the third quar...the quarter ended September 30, 2009 improved to $...net loss of $37.0 million or $0.40 per share in th... to make improvements to its operating efficiencie...
Breaking Biology Technology:Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3DIATHERIX Laboratories Presents at Homeland Security Conference 2Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10
...axa Corporation announces its,2008 sponsorship for...Board,Chair Jack Wheeler (founder of MicroPhage In...ociation sponsors, during the CBSA Annual All-Memb...in Denver. Baxa Corporation,has been a member of t...,Baldwin was one of the founders and the first Pre...
...Representatives Unveil State-of-the-Art Facility ...ILLE, Md., May 1 Officials from Novavax,Inc. (Nas... County today,celebrated the opening of Novavax,s ...t the company,s headquarters in Rockville, Marylan...mercial-scale manufacturing plant will,be used to ...
...rmo Fisher,Scientific Inc. (NYSE: TMO ) announced...of Tuesday, May 20, 2008, starting at 9:00 a.m. (E...rand Central, in New York City., The meeting will...,Scientific,s senior management team, who will pro...tations for future financial performance., You ma...
Other Biology Technology:Baxa Announces Colorado BioScience Association Sponsorship 2Baxa Announces Colorado BioScience Association Sponsorship 3Novavax Opens Its First U.S. Vaccine Plant 2Novavax Opens Its First U.S. Vaccine Plant 3Novavax Opens Its First U.S. Vaccine Plant 4Thermo Fisher Scientific to Host Analyst Meeting 2
(Date:11/4/2009)...L Scientists at the University of North Carolina ...ty of California, San Francisco have developed and...target diseases for existing drugs. , The resear...es how similar the structures of all known drugs a...known as ligands -- of disease targets within the ...
(Date:11/3/2009)...EMBER 4, 2009 -- The world,s greatest wines are t...ty, human input, and something called the "terroir...il, and climate. , Experts will discuss terroi...on Wednesday, Nov. 4 in Pittsburgh. "Terroir: Win...two parts at the 2009 Annual Meetings of the Ameri...
(Date:11/3/2009)...In a research report published in a recent issue o... Sim Alegre examined the effects of covering orcha...uit quality, canopy light distribution, orchard te... performed using Extenday and Solarmate films inst...s of ,Mondial Gala, apples. The research showed th...
Breaking Biology News(10 mins):Study points to new uses, unexpected side effects of already existing drugs 2Great wines come from great soils 2Reflective film can boost profits for apple growers 2A comprehensive review of addiction to prescription painkillers among patients and physicians 51008 1A comprehensive review of addiction to prescription painkillers among patients and physicians 51008 2A comprehensive review of addiction to prescription painkillers among patients and physicians 51008 3Denosumab Demonstrates Superiority Over Zometa 28R 29 in Pivotal Phase 3 Head to Head Trial in Breast Cancer Patients With Bone Metastases 4698 1Denosumab Demonstrates Superiority Over Zometa 28R 29 in Pivotal Phase 3 Head to Head Trial in Breast Cancer Patients With Bone Metastases 4698 2Denosumab Demonstrates Superiority Over Zometa 28R 29 in Pivotal Phase 3 Head to Head Trial in Breast Cancer Patients With Bone Metastases 4698 3Denosumab Demonstrates Superiority Over Zometa 28R 29 in Pivotal Phase 3 Head to Head Trial in Breast Cancer Patients With Bone Metastases 4698 4Denosumab Demonstrates Superiority Over Zometa 28R 29 in Pivotal Phase 3 Head to Head Trial in Breast Cancer Patients With Bone Metastases 4698 5Denosumab Demonstrates Superiority Over Zometa 28R 29 in Pivotal Phase 3 Head to Head Trial in Breast Cancer Patients With Bone Metastases 4698 6Denosumab Demonstrates Superiority Over Zometa 28R 29 in Pivotal Phase 3 Head to Head Trial in Breast Cancer Patients With Bone Metastases 4698 7Denosumab Demonstrates Superiority Over Zometa 28R 29 in Pivotal Phase 3 Head to Head Trial in Breast Cancer Patients With Bone Metastases 4698 8Zix Corporation CEO Provides Corporate Update for Second Quarter 2009 51001 1Zix Corporation CEO Provides Corporate Update for Second Quarter 2009 51001 2Zix Corporation CEO Provides Corporate Update for Second Quarter 2009 51001 3Zix Corporation CEO Provides Corporate Update for Second Quarter 2009 51001 4
...am of researchers has identified a new genetic mut..., a condition that makes bones much more likely to...e journal Cell. , Victims may experience just a ...inning before birth. The number of Americans affec... 50,000. While the study is an important early ste...
...nnovative new NASA-funded study based on a combina...r balloon readings finds that smoke from Alaskan a...-level ozone thousands of miles away in Houston du...ch will appear online Sept. 26 in the Journal of G...pse at the precise air-quality effects from pollut...
...chnique used since the 1930s to estimate the abund...orcement patrols are effective at reducing poachin... in the Serengeti National Park in Tanzania. , "...g threat from the bushmeat and illegal trophy trad...ed areas is not sufficient to protect wildlife. So...
Other Biology News:Researchers discover new gene responsible for brittle bone disease 2Researchers discover new gene responsible for brittle bone disease 3NASA study: Alaskan fires affected Houston air quality in 2004 2NASA study: Alaskan fires affected Houston air quality in 2004 3Serengeti patrols cut poaching of buffalo, elephants, rhinos 2
...aging and analysis system is an integrated hardwar...pid acquisition and analysis of fluorescence image...Xpress is fast. Scanning an entire 384-well plate ...fluorescence images per well, takes less than 13 m...
Earle's Balanced Salt Solution, 10x (EBSS) from Sigma-Aldrich
...lined immunospot) Kit analyzes interferon gamma (I...spot forms at the site where secreted cytokine is ...scope or automated ELISPOT reader) and then compar... This allows the frequency of cells secreting the ...
Corning Roller Bottle Easy Grip Caps, Sterile from Sigma-Aldrich
Biology Products: